Saturday, 31 October 2026European Markets

BYGGMA Stock Bullish Momentum With A 10% Rise So Far Today

Loading stream...

(VIANEWS) - Shares of BYGGMA (Oslo Børs Benchmark Index_GI: BMA.OL) jumped by a staggering 10.98% to kr27.30 at 11:22 EST on Tuesday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI is rising 0.12% to kr1,218.16, after two successive sessions in a row of gains. This seems, up until now, a somewhat positive trend trading session today.

About BYGGMA

Byggma ASA manufactures and supplies building materials in Norway, Sweden, Denmark, Finland, the United Kingdom, the Netherlands, and internationally. It offers pre-painted ceilings and wall panels under the Huntonit brand name; I-beams for use in ceilings, walls, and floors in wood-based buildings under the brand name of Masonite; and particle boards, boards, and structural panels for use in buildings, interior ceilings, and wall panels under the Forestia brand name. The company also provides home lighting products under the Scan Lamps brand name; doors and windows for new buildings, extensions, and rehabilitation under the brand name of Uldal; a range of lamp and lighting products under the Aneta brand name; and develops, manufactures, and distributes MDF panels for walls, ceilings, bathrooms, and kitchens under the brand name of Smartpanel, as well as supplies OSB plywood and building boards under the brand name of Byggform. It exports its products. Byggma ASA is headquartered in Vennesla, Norway. Byggma ASA operates as a subsidiary of Investor As.

Earnings Per Share

As for profitability, BYGGMA has a trailing twelve months EPS of kr3.58.

PE Ratio

BYGGMA has a trailing twelve months price to earnings ratio of 7.63. Meaning, the purchaser of the share is investing kr7.63 for every norwegian krone of annual earnings.

Volatility

BYGGMA's last week, last month's, and last quarter's current intraday variation average was a positive 1.63%, a negative 0.32%, and a positive 1.75%.

BYGGMA's highest amplitude of average volatility was 1.63% (last week), 1.98% (last month), and 1.75% (last quarter).

More news about BYGGMA (BMA.OL).

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com